Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Amit Bhalerao"'
Autor:
Deshpande Janhavi JAYWANT, Amit BHALERAO, Vikas RATNAPARKHI, Suryakant NISALE, Pranav SHAMRAJ, Ujjwala KULKARNI, Sunil KOTKUNDE, Nitin KESARKAR, Sagar NANAWARE, Vikas DEOKAR, Chaitanya MADKAR, Ravi SING
Publikováno v:
Modern Medicine, Vol 28, Iss 4, Pp 397-400 (2021)
Background: Coronary Heart Disease (CHD) is widely prevalent across the globe and significantly high level of Cholesterol in circulation is a single major risk factor associated with coronary heart disease. It is well established that cardiovascular
Externí odkaz:
https://doaj.org/article/a613e674f7524bdab945d51214a140bf
Autor:
Amit Bhalerao, Varsha S. Suryavanshi, Anjana Sahu, Swati Chhatrapati, Manish Patil, Harshwardhan Tikle
Publikováno v:
Neuromodulation: Technology at the Neural Interface. 26:S13
Autor:
Salunkhe Videsh, Madhu bala, Avinash Dhanave, Tanaji Mengawade, Vamsi Madgula, Mahesh Thakkar, Keshav Naik, Bheemashankar Kulkarni, Rahul D. Kaduskar, Dhananjay N. Umrani, Santosh Kurhade, Sachin Joshi, Amit Bhalerao, Sreekanth R. Rouduri, Vishal V Pathade, Rajkanth Petla, Swagatam Ray, Narayanan Hariharan, Kasim A. Mookhtiar, Satheesh Veerappa Avaragolla, Debnath Bhuniya, Jagadeesh Mavinahalli, Ashwini Tambe, Vaibhav Jain, Siddhartha De, Amol A. Raje, Ahmed Nadeem
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 27:1867-1873
In a pursuit to identify reversible and selective BTK inhibitors, two series based on 7H-pyrrolo[2,3-d]pyrimidine and 1H-pyrrolo[2,3-b]pyridine as the hinge binding core, have been identified. Structure activity relationship (SAR) exploration led to
Autor:
Zaki Munshi, Dibyendu Mondal, Velavan Armugam, Frank M. Dautzenberg, Claude Ostermann, Amit Bhalerao, Vinod Gudaghe, Guido Hanauer, Nisha Pansare, Koushik Das Sarma, Mahendra Gupta, Klaus Mann, Pramila Rayudu, Michaela Schaefer, Sandra Nappe, Afsar Ali Siddiki, Cornelia Weiss-Haljiti, Christof Zitt, Hans-Peter Kley, Yithachu Thur
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 22:7314-7321
SAR studies were performed on a series of 2-arylamido-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxamide derivatives as cannabinoid receptor agonists. Starting from a HTS hit both potency and selectivity could be improved. Modifications to the thiophene